🇺🇸 FDA
Patent

US 11458173

Synergistic bacterial compositions and methods of production and use thereof

granted A61KA61K35/74A61K35/742

Quick answer

US patent 11458173 (Synergistic bacterial compositions and methods of production and use thereof) held by Seres Therapeutics, Inc. expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Seres Therapeutics, Inc.
Grant date
Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K35/74, A61K35/742, A61K38/13, A61K45/06